Rhumbline Advisers Sci Sparc Ltd. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023
BUY
$0.43 - $0.83 $386 - $745
898 New
898 $0

Others Institutions Holding SPRC

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About SciSparc Ltd.

SPRC Quotes by TradingView
  • Ticker SPRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 3,526,740
  • Market Cap $1.52M
  • Description
  • SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum ...
More about SPRC
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email